A Study to Assess Adverse Events and Change in Disease Activity of HArmonyCa Lidocaine Injectable Gel for Mid Face Soft Tissue Augmentation in Adult Participants
- Conditions
- Mid Face Volume Deficit
- Interventions
- Device: HArmonyCa Lidocaine Injectable Gel
- First Posted Date
- 2022-07-11
- Last Posted Date
- 2024-06-20
- Lead Sponsor
- Allergan
- Target Recruit Count
- 171
- Registration Number
- NCT05452070
- Locations
- 🇨🇦
Humphrey & Beleznay Cosmetic Dermatology /ID# 239805, Vancouver, British Columbia, Canada
🇨🇦Dermetics Cosmetic Dermatology /ID# 246536, Burlington, Ontario, Canada
🇨🇦The Centre for Clinical Trials /ID# 246409, Oakville, Ontario, Canada
Study of AGN-190584 Eye Drops to Assess Safety and Efficacy in Participants Aged 40-80 Years With Pseudophakic Presbyopia
- Conditions
- Presbyopia
- Interventions
- Drug: VehicleDrug: AGN-190584
- First Posted Date
- 2022-05-26
- Last Posted Date
- 2022-06-29
- Lead Sponsor
- Allergan
- Registration Number
- NCT05393089
- Locations
- 🇺🇸
Global Research Management /ID# 243544, Glendale, California, United States
🇺🇸United Medical Research Institute /ID# 243531, Inglewood, California, United States
🇺🇸Salvay Vision /ID# 243828, Newport Beach, California, United States
A Study to Assess Adverse Events and Change in Disease Activity of Intramuscular AGN-151586 Injection in Toxin-Naïve Adult Participants With Glabellar Lines
- Conditions
- Glabellar Lines
- Interventions
- Drug: AGN-151586Drug: Placebo
- First Posted Date
- 2022-02-21
- Last Posted Date
- 2024-01-10
- Lead Sponsor
- Allergan
- Target Recruit Count
- 309
- Registration Number
- NCT05248880
- Locations
- 🇨🇦
YVR Aesthetics Training & Study Centre /ID# 241858, Vancouver, British Columbia, Canada
🇺🇸Delricht Research - 10154 Jefferson /ID# 244890, Baton Rouge, Louisiana, United States
🇺🇸DMR Research PLLC /ID# 239061, Westport, Connecticut, United States
A Study To Assess the Adverse Effects and Change in Condition of OnabotulinumtoxinA X Injection in Adult Participants With Forehead Lines
- First Posted Date
- 2021-12-10
- Last Posted Date
- 2023-08-14
- Lead Sponsor
- Allergan
- Target Recruit Count
- 124
- Registration Number
- NCT05152576
- Locations
- 🇺🇸
The Center for Dermatology Cosmetics & Laser Surgery /ID# 239776, Mount Kisco, New York, United States
🇺🇸Dermatology Consulting Service /ID# 239779, High Point, North Carolina, United States
🇺🇸Steve Yoelin MD Medical Assoc. Inc /ID# 239771, Newport Beach, California, United States
HArmonyCa Injectable Gel for Mid Face Soft Tissue Augmentation
- Conditions
- Soft Tissue Augmentation
- Interventions
- Device: HArmonyCa Injectable Gel
- First Posted Date
- 2021-11-15
- Last Posted Date
- 2023-10-05
- Lead Sponsor
- Allergan
- Target Recruit Count
- 140
- Registration Number
- NCT05119777
- Locations
- 🇫🇷
Eurofins Dermscan Pharmascan /ID# 240921, Aix-en-Provence, France
🇫🇷Eurofins Pharmascan /ID# 240920, Lyon, France
A Study to the Assess the Change in Condition and Adverse Events of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines
- First Posted Date
- 2021-10-29
- Last Posted Date
- 2023-11-07
- Lead Sponsor
- Allergan
- Target Recruit Count
- 328
- Registration Number
- NCT05100199
- Locations
- 🇺🇸
Coleman Center For Cosmetic Dermatologic Surgery /ID# 230693, Metairie, Louisiana, United States
🇺🇸Etre Cosmetic Dermatology and Laser Center /ID# 230437, New Orleans, Louisiana, United States
🇺🇸The Eye Research Foundation /ID# 232544, Newport Beach, California, United States
Study to Assess Effectiveness and Adverse Events of JUVEDERM VOLBELLA With Lidocaine Injection in Correcting Infraorbital Hollowing in Chinese Adult Participants
- Conditions
- Infraorbital Hollowing
- Interventions
- Device: VOLBELLA with Lidocaine
- First Posted Date
- 2021-10-22
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- Allergan
- Target Recruit Count
- 160
- Registration Number
- NCT05088980
- Locations
- 🇨🇳
Zhongda Hospital Southeast University /ID# 241040, Nanjing, Jiangsu, China
🇨🇳Nanjing Drum Tower Hospital /ID# 241042, Nanjing, Jiangsu, China
🇨🇳Peking University First Hospital /ID# 227593, Xicheng District, Beijing, China
VFORM: Prospective, Open Label, Study to Evaluate VOLIFT With Lidocaine Treatment for FORehead Contouring and Marionette Lines
- Conditions
- Marionette Lines Forehead Contouring
- Interventions
- Device: Juvéderm® VOLIFT™ with Lidocaine
- First Posted Date
- 2021-10-14
- Last Posted Date
- 2022-11-30
- Lead Sponsor
- Allergan
- Target Recruit Count
- 163
- Registration Number
- NCT05077488
- Locations
- 🇫🇷
Eurofins Pharmascan /ID# 243454, Lyon, France
A Study of OnabotulinumtoxinA X Injection in Adult Participants With Glabellar Lines
- First Posted Date
- 2021-08-19
- Last Posted Date
- 2023-06-13
- Lead Sponsor
- Allergan
- Target Recruit Count
- 92
- Registration Number
- NCT05013424
- Locations
- 🇺🇸
Etre Cosmetic Dermatology and Laser Center /ID# 227365, New Orleans, Louisiana, United States
🇺🇸Advanced Research Associates - Glendale /ID# 227368, Glendale, Arizona, United States
🇺🇸Austin Institute for Clinical Research /ID# 227367, Pflugerville, Texas, United States
A Study to Assess Safety and Efficacy in Participants Age 40 to 55 With Presbyopia (Old Eye) Who Receive AGN-190584 in Both Eyes Twice Daily
- First Posted Date
- 2021-07-30
- Last Posted Date
- 2023-03-21
- Lead Sponsor
- Allergan
- Target Recruit Count
- 230
- Registration Number
- NCT04983589
- Locations
- 🇺🇸
Martel Eye Medical Group /ID# 231332, Rancho Cordova, California, United States
🇺🇸North Valley Eye Medical Group, Inc. /ID# 231270, Mission Hills, California, United States
🇺🇸Global Research Management /ID# 231300, Glendale, California, United States